Improving Lives for Less
New data from the 2013 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system and patients $217 billion in 2012. That’s $1.3 trillion dollars in the most recent decade. In 2012 alone, savings for the retail markets totaled $171 billion. Generics have saved out-of-pocket cash payers $78 billion over the past 10 years – these typically are the uninsured and poorer customers. All data were compiled by IMS Health on behalf of GPhA. learn more >
2012 Annual Report
Vision. In 2012, GPhA transformed its vision into action to improve health care outcomes for millions of patients across the U.S., and made unprecedented progress on the goal to expand access to high quality, more affordble medicines.
The vision theme of the 2012 annual report communicates GPhA's conviction that the first step toward building a successful future is developing the ability to envision it. learn more >